Logo image of IMUC

IMMUNOCELLULAR THERAPEUTICS (IMUC) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:IMUC - US4525362046

0.053
-0.17 (-75.91%)
Last: 10/16/2018, 8:13:46 PM
No Fundamental Analysis report for IMUC not available.

IMMUNOCELLULAR THERAPEUTICS / IMUC FAQ

What is the fundamental rating for IMUC stock?

ChartMill assigns a fundamental rating of 2 / 10 to IMUC.


Can you provide the valuation status for IMMUNOCELLULAR THERAPEUTICS?

ChartMill assigns a valuation rating of 3 / 10 to IMMUNOCELLULAR THERAPEUTICS (IMUC). This can be considered as Overvalued.


Can you provide the profitability details for IMMUNOCELLULAR THERAPEUTICS?

IMMUNOCELLULAR THERAPEUTICS (IMUC) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for IMUC stock?

The Earnings per Share (EPS) of IMMUNOCELLULAR THERAPEUTICS (IMUC) is expected to decline by -100% in the next year.


Can you provide the dividend sustainability for IMUC stock?

The dividend rating of IMMUNOCELLULAR THERAPEUTICS (IMUC) is 0 / 10 and the dividend payout ratio is 0%.